Atropine is NOT routinely given before every pediatric intubation
Based on the most recent 2025 AHA/AAP guidelines, atropine use as premedication for pediatric emergency intubation is optional and should be reserved for select high-risk situations, not administered universally. 1
Current Guideline Recommendation
The 2025 American Heart Association and American Academy of Pediatrics guidelines provide a Class 2b recommendation (weak) stating that "it may be reasonable to use atropine as a premedication to prevent bradycardia in infants and children during emergency intubation" 1. This represents a significant shift from older practices that advocated more routine use.
Key Points from the Guidelines:
- No survival benefit demonstrated: There is no evidence that preintubation atropine improves survival or prevents cardiac arrest in pediatric patients 1
- Mixed evidence on bradycardia prevention: While two prospective observational studies from 2007-2009 showed associations with decreased ICU mortality and reduced bradycardia, four retrospective studies found no association between atropine use and bradycardia occurrence 1
- Limited evidence quality: The recommendation is based on low-quality observational data (Level of Evidence: C-LD) 1
When to Consider Atropine Use
Atropine may be reasonable in specific high-risk scenarios:
- Infants and young children (particularly those under 8 years old, especially infants who are most susceptible to vagally-mediated bradycardia) 1, 2
- When using succinylcholine as the neuromuscular blocker 3
- Septic shock or hypovolemia where bradycardia could precipitate hemodynamic collapse 2
- Patients aged 28 days to 8 years in PICU settings with cardiovascular instability 2
Dosing When Used
If atropine is administered, the 2025 guidelines recommend:
- Dose: 0.02 mg/kg with no minimum dose 1
- This eliminates the historical 0.1 mg minimum dose requirement, which was based on weak evidence from a 1971 study 1
Evolution of Practice
This represents a reversal from older dogma:
- 2015 AHA Guidelines: Already stated that "available evidence does not support the routine use of atropine preintubation" but allowed for selective use 3
- 2025 Guidelines: Further weakened the recommendation to "may be reasonable" (Class 2b) rather than mandatory 1
- The shift reflects recognition that previous guidelines discouraged routine administration and that evidence supporting universal use is lacking 1
Supporting Evidence Against Routine Use
Recent research challenges routine atropine administration:
- A 2023 observational study found atropine did not prevent hypoxemia or bradycardia during pediatric emergency department intubations; paradoxically, atropine was associated with higher odds of bradycardia in multivariable analysis 4
- A 2022 study showed low bradycardia incidence (4.8%) regardless of atropine use, with similar rates between atropine and non-atropine groups 5
- Multiple studies demonstrate that bradycardia during pediatric intubation is less common than historically believed 5, 6, 7
Clinical Algorithm
Assess the clinical scenario:
- Emergency intubation in stable patient without high-risk features → Atropine NOT routinely needed
- Infant (<1 year) or young child (<8 years) with:
- Septic shock/hypovolemia, OR
- Plan to use succinylcholine, OR
- Cardiovascular instability → Consider atropine 0.02 mg/kg IV
- Older child (>8 years) with stable hemodynamics → Atropine generally NOT indicated
Important Caveats
- Atropine does not prevent all bradycardia: Some patients will experience bradycardia regardless of pretreatment 6
- Hypoxemia and adequate ventilation are the priority: Oxygenation and ventilation are essential first maneuvers; epinephrine is the drug of choice if bradycardia persists despite adequate oxygenation 1
- Multiple causes of peri-intubation bradycardia exist: Including hypoxemia, underlying disease, medications (succinylcholine, fentanyl), transition to positive pressure ventilation, and vagal stimulation 1
- No minimum dose required: The historical 0.1 mg minimum to prevent "paradoxical bradycardia" is no longer supported 1
Bottom Line
Atropine should NOT be given routinely before every pediatric intubation. Its use should be selective, reserved for high-risk situations involving young infants, hemodynamically unstable patients, or when using succinylcholine. The focus should remain on optimizing oxygenation and ventilation as the primary interventions to prevent bradycardia.